InvestorsHub Logo
Followers 87
Posts 6642
Boards Moderated 1
Alias Born 09/18/2009

Re: TankTheFrank post# 41091

Monday, 11/27/2023 11:16:25 PM

Monday, November 27, 2023 11:16:25 PM

Post# of 42751
The article stated that owners of 53% of shares in Xspray have declared their intention to exercise warrants. "The company’s Chairman, CEO and CFO have also declared the same intent." That doesn't suggest to me that all of the shareholders have been identified.

I mention this because the surreptitious control of an entity, through the exercise of warrants, was part of the news announced with the previous recall of our loaned shares. In addition, this company is where Ed Jordan is now the chief commercial officer. It's feasible that we will see that Humanigen has taken an ownership stake in the company, even if it doesn't amount to control.

https://xspraypharma.com/modular_finance_pressmeddelande/xspray-pharma-appoints-chief-commercial-officer-to-drive-upcoming-dasynoc-us-product-commercialization/

Lenz could prove to have a pivotal role in eliminating the black box warning for Xspray's nilotinib (TASIGNA) in the US.

https://xspraypharma.com/modular_finance_pressmeddelande/xspray-pharmas-xs003-achieves-superior-bioavailability-milestone-matching-tasigna-at-reduced-dosage/